type 2 diabetes

Merck bags global rights to NGM NASH drug, plans phase 2b trial
Merck bags global rights to NGM NASH drug, plans phase 2b trial
Fierce Biotech
Merck
NASH
NGM Biopharmaceuticals
type 2 diabetes
clinical trials
MK-3655
Flag link:
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
FDA Slaps Clinical Hold on Zafgen’s Lead Product Over Safety Concerns
BioSpace
Zafgen
clinical trials
FDA
diabetes
ZGN-1061
type 2 diabetes
Flag link:
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Novo Nordisk
semaglutides
type 2 diabetes
clinical trials
cardiovascular outcomes
Flag link:
Millions left behind as diabetes drives surge in insulin demand
Millions left behind as diabetes drives surge in insulin demand
Reuters
diabetes
type 2 diabetes
insulin
Flag link:
A startup for diabetes patients rolls out a new model: Insurers only pay if the service works
A startup for diabetes patients rolls out a new model: Insurers only pay if the service works
Stat
devices
digital coaching
type 2 diabetes
Virta Health
Flag link:
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Questions Raised About Invokana Label Expansion For CV Risk Reduction
Forbes
Janssen
JNJ
Invokana
type 2 diabetes
Flag link:
Johnson & Johnson bags long-awaited cardiovascular nod for diabetes drug Invokana
Johnson & Johnson bags long-awaited cardiovascular nod for diabetes drug Invokana
Fierce Pharma
JNJ
Invokana
type 2 diabetes
Flag link:
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Fierce Pharma
patients
patient experience data
Sanofi
Novo Nordisk
type 2 diabetes
Flag link:
AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells
AstraZeneca and Ionis target diabetes with antisense approach to regenerating pancreatic cells
Fierce Biotech
AstraZeneca
Ionis Pharmaceuticals
type 2 diabetes
antisense
Flag link:
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
CP Wire
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
New Analysis Suggests that Jardiance Could Add Years to Life Expectancy of Adults With Type 2 Diabetes and Cardiovascular Disease
CP Wire
Jardiance
Boehringer Ingelheim
Eli Lilly
diabetes
type 2 diabetes
Flag link:
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Eli Lilly's diabetes treatment meets main goal in two late-stage studies
Reuters
Eli Lilly
Ultra Rapid Lispro
Humalog
diabetes
type 1 diabetes
type 2 diabetes
Flag link:
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
Lilly Licenses Chugai Pharma's Oral Diabetes Drug for $50 Million Upfront
BioSpace
Eli Lilly
Chugai
OWL833
type 2 diabetes
Flag link:
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
Farxiga Meets One Primary Endpoint in Large Ph III Cardiovascular Outcomes Trial in 17,000 Patients with Type 2 Diabetes
CP Wire
AstraZeneca
Farxiga
Dapagliflozin
clinical trials
type 2 diabetes
cardiovascular disease
Flag link:
How One Class Of Diabetes Medications May Lead To Flesh-Eating Genital Infections
How One Class Of Diabetes Medications May Lead To Flesh-Eating Genital Infections
Forbes
FDA
type 2 diabetes
SGLT2 inhibitor
Flag link:
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Flag link:
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
Amgen's Repatha Reduces Bad Cholestrol in Type II Diabetes
NASDAQ.com
Amgen
Repatha
type 2 diabetes
diabetes
hypercholesterolemia
ADA
Flag link:
How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab
How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab
Forbes
ASCO 2018
lung cancer
type 2 diabetes
metformin
Flag link:
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Japan approves Novo Nordisk’s once-weekly Type II diabetes drug
Drug Delivery Business News
Japan
Novo Nordisk
diabetes
type 2 diabetes
Ozempic
Flag link:

Pages